HBV Genotype-Specific Levels of Hepatitis B Surface Antigen Improve HBV Phenotype Definition

Hepatitis B Research Network

Research output: Contribution to journalShort surveypeer-review

Abstract

Controversies exist regarding the classification of the different clinical phases of chronic hepatitis B (CHB) because hepatitis B virus (HBV) DNA and alanine aminotransferase levels fluctuate over time.1,2 To improve the distinction of clinical phases and the associated spectrum of clinical outcome,3,4 hepatitis B surface antigen (HBsAg) levels may be of help.5–7 We hypothesize that HBV genotype specific HBsAg levels are needed for the identification of different clinical HBV disease phases.7

Original languageEnglish (US)
Pages (from-to)259-261
Number of pages3
JournalClinical Gastroenterology and Hepatology
Volume18
Issue number1
DOIs
StatePublished - Jan 2020

Bibliographical note

Funding Information:
Funding The HBRN was funded by as a Cooperative Agreement between the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to the following investigators Lewis R. Roberts, MB, ChB, PhD (U01-DK082843), Anna Suk-Fong Lok, MD (U01-DK082863), Steven H. Belle, PhD, MScHyg (U01-DK082864), Kyong-Mi Chang, MD (U01-DK082866), Michael W. Fried, MD (U01-DK082867), Adrian M. Di Bisceglie, MD (U01-DK082871), William M. Lee, MD (U01 DK082872), Harry L. A. Janssen, MD, PhD (U01-DK082874), Daryl T-Y Lau, MD, MPH (U01-DK082919), Richard K. Sterling, MD, MSc (U01-DK082923), Steven-Huy B. Han, MD (U01-DK082927), Robert C. Carithers, MD (U01-DK082943), Norah A. Terrault, MD, MPH (U01-DK082944), an interagency agreement with NIDDK: Lilia M. Ganova-Raeva, PhD (A-DK-3002-001) and support from the intramural program, NIDDK, National Institutes of Health (NIH): Marc G. Ghany, MD. Additional funding to support this study was provided to Kyong-Mi Chang, MD, the Immunology Center, (NIH/NIDDK Center of Molecular Studies in Digestive and Liver Diseases P30DK50306, NIH Public Health Service Research Grant M01 RR00040), Richard K. Sterling, MD, MSc (UL1TR000058, NCATS (National Center for Advancing Translational Sciences, NIH), Norah A. Terrault, MD, MPH (CTSA Grant Number UL1TR000004), Michael W. Fried, MD (CTSA Grant Number UL1TR001111) and Anna Suk-Fong Lok (CTSA Grant Number UL1RR024986, U54 TR001959 U54TR001959.) Additional support was provided by Gilead Sciences, Inc. and Roche Molecular Systems via a CRADA through the NIDDK. The NIDDK (NIH) provided financial support for each of the clinical centers and a data coordinating center though a cooperative agreement. NIDDK project officers and scientists participate in meetings of the network investigators and offer suggestions on data analysis. The funding source did not have influence on analysis and interpretation of the data, writing of the report or the decision to submit for publication.

Publisher Copyright:
© 2020 AGA Institute

Fingerprint

Dive into the research topics of 'HBV Genotype-Specific Levels of Hepatitis B Surface Antigen Improve HBV Phenotype Definition'. Together they form a unique fingerprint.

Cite this